Page 31 - Journal of Special Operations Medicine - Spring 2014
P. 31

3.  Butler F, Giebner S, McSwain N, et al. Prehospital Trauma   22.  Naval Operational Medical Lessons Learned Center.
                 Life Support Manual; Seventh Edition–Military Version.   Combat Medical Personnel Evaluation of Battlefield
                 November 2010.                                     Trauma Care Equipment Initial Report. November 2011.
                4.  Hennes H, Kim M, Pirrallo R. Prehospital pain manage-  23.  Holbrook T, Galarneau M, Dye J, et al. Morphine use
                 ment: a comparison of providers’ perceptions and prac-  after combat injury in Iraq and post-traumatic stress dis-
                 tices. Prehosp Emerg Care. 2005;9:32–39.           order. N Engl J Med. 2010;362:110–117.
                5.  Kotwal R, Butler F, Edgar E, et al. Saving lives on the battle-  24.  O’Connell R, Winstead J, Matthews J. Morphine after
                 field: A Joint Trauma System review of pre-hospital trauma   combat injury and post-traumatic stress disorder. N Engl
                 care in Combined Joint Operating Area–Afghanistan    J Med. 2010;362:1341.
                 (CJOA-A). Joint Trauma System; U.S. Army Institute of   25.  Lichtor J, Sevarino F, Joshi G, et al. The relative potency
                 Surgical Research; Joint Base Fort Sam Houston Report;   of oral transmucosal fentanyl citrate compared with intra-
                 30 January 2013.                                   venous morphine in the treatment of moderate to severe
                6.  Buckenmaier C, Rupprecht C, McKnight G, et al. Pain   postoperative pain. Anesth Analg. 1999;89:732–738.
                 following battlefield injury and evacuation: a survey of   26.  Mystakidou K, Katsouda E, Parpa E, et al. Oral trans-
                 110 casualties from the wars in Iraq and Afghanistan.   muscosal fentanyl citrate: overview of pharmacologic and
                 Pain Med. 2009:10:1487–1495.                       clinical characteristics. Drug Deliv. 2006:13:269–276.
                7.  Aronoff G, Brennan M, Pritchard D, Ginsberg B.   27.  Mahar P, Rana J, Kennedy C, Christopher N. A random-
                   Evidence-based oral transmucosal citrate (OTFC) dosing   ized clinical trial of oral transmucosal fentanyl citrate
                 guidelines. Pain Med. 2005;6:305–314.              versus intravenous morphine sulfate for initial control of
                8.  Buckenmaier C. The role of pain management in recovery   pain in children with extremity injuries. Pediatric Emerg
                 following trauma and orthopaedic surgery.  J Am Acad   Care. 2007;23:544–548.
                 Orthop Surg. 2012;20:s35–s38.                   28.  MacIntyre  P,  Margetts  L,  Larsen  D,  Barker  L.  Oral
                9.  Kent M, Upp J, Buckenmaier C. Acute pain on and off the   transmucosal fentanyl citrate versus placebo for painful
                 battlefield: what we do, what we know, and future direc-  dressing changes: a crossover trial. J Wound Care. 2007;
                 tions. Int Anesthesiol Clin. 2011;49:10–32.        16:118–121.
              10.  Beecher H. Delayed morphine poisoning in battle casual-  29.  Landy S: Oral transmucosal fentanyl citrate for the treat-
                 ties. JAMA. 1944;124:1193–1194.                    ment of migraine headache pain in outpatients: a case se-
              11.  Buckenmaier C, Brandon-Edwards H, Borden D, Wright   ries. Headache. 2004;44:762–766.
                 J. Treating pain on the battlefield: a warrior’s perspective.   30.  Lind G, Marcus M, Mears S, et al. Oral transmucosal fen-
                 Curr Pain Headache Rep. 2010;14:1–7.               tanyl citrate for analgesia and sedation in the emergency
              12.  Butler F, Hagmann J, Butler E. Tactical combat casualty   department. Ann Emerg Med. 1991;20:1117.
                 care  in  Special  Operations.  Mil  Med.  1996;161(Suppl   31.  Kotwal R, Montgomery H, Kotwal B, et al. Eliminating
                   August).                                         preventable death on the battlefield. Arch Surg. 2011;146:
              13.  Kotwal R, O’Connor K, Johnson T, et al. A novel pain   1350–1358.
                 management strategy for combat casualty care.  Ann   32.  Kacprowicz R, Johnson T, Mosely D. Fentanyl for pain
                 Emerg Med. 2004;44:121–127.                        control in Special Operations. J Spec Oper Med. 2008;
              14.  Afghanistan Regional Command (South) Commander   8:48–53.
                 Approval Memo for the Use of OTFC dated 19 June   33.  Caravalho J. OTSG Dismounted Complex Blast Injury
                 2011.                                              Task Force; Final Report. Office of the U.S. Army Sur-
              15.  Dickey N. Prehospital use of ketamine in battlefield an-  geon General; Falls Church, VA; 18 June 2011:44–47.
                 algesia. Defense Health Board Memorandum. 8 March   34.  Wedmore I, et al. Pain management in the wilderness
                 2012.                                              and operational setting. Emerg Med Clin N Am. 2005;
              16.  Kotwal R, Butler F, Montgomery H, et al. The Tactical   23:585–601.
                 Combat Casualty Care Casualty Card. J Spec Oper Med.   35.  Schmid R,  Sandler A, Katz  J. Use  and efficacy  of low-
                 2013;13:82–87.                                     dose ketamine in the management of acute postoperative
              17.  Wedmore I, Kotwal R, McManus J, et al. Safety and effi-  pain: a review of current techniques and outcomes. Pain.
                 cacy of oral transmucosal fentanyl citrate for prehospital   1999;82:111–125.
                 pain control on the battlefield. J Trauma Acute Care Surg.   36.  Porter K. Ketamine in prehospital care.  Emerg Med J.
                 2012;73:S490–S495.                                 2004;21:351–354.
              18.  Hocking G. Battlefield analgesia; an advance approach. J   37.  Heshmati F, Zeinali M, Abbacivash R, Mahoori A. Use
                 R Army Med Corps. 1999;145:116–118.                of ketamine in severe status asthmaticus in intensive care
              19.  Feuerstein G, Siren A. Effect of naloxone and morphine on   unit. Iran J Allergy Asthma Immunol. 2003:2:175–180.
                 survival of conscious rats after hemorrhage. Circ Shock.   38.  Green S, Roback M, Kennedy R, Krauss B. Clinical prac-
                 1986;19:293–300.                                   tice guideline for emergency department dissociative
              20.  Alonso-Serra H, Wesley K, National Association of EMS     sedation: 2011 update. Ann Emerg Med. 2011;57:449–
                 Physicians Standards and Clinic Practices Committee. Pre-  461.
                 hospital pain management. Prehosp Emerg Care. 2003;7:   39.  Filanovsky Y, Miller P, Kao J. Myth: ketamine should not
                 482–488.                                           be used as an induction agent for intubation in patients
              21.  Stiell I, Nesbitt L, Pickett W, et al. The OPALS major   with head injury. CJEM. 2010;12:154–157.
                 trauma study: impact of advanced life-support on sur-  40.  Mayberg T, Lam A, Matta B, et al. Ketamine does not in-
                 vival and morbidity. CMAJ. 2008:1141–1152.         crease cerebral blood flow velocity or intracranial  pressure



              Triple-Option Analgesia Plan for TCCC                                                           23
   26   27   28   29   30   31   32   33   34   35   36